Work

Selective and Orally Bioavailable c-Met PROTACs for the Treatment of c-Met-Addicted Cancer

Year: 2024

Type: article

Source: Journal of Medicinal Chemistry

DOI: 10.1021/acs.jmedchem.3c02417

Authors: Shilong Ying, Hongli Chi, Xiaoqiu Wu, Pingping Zeng, Jinling Chen, Ting Fu, Weitao Fu, Penghui Zhang, Weihong Tan

Institutions: Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Zhejiang University of Technology, Shanghai Jiao Tong University, Renji Hospital

Language: English

Topic: Protein Degradation and Inhibitors

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Natural Science Foundation of China, National Health Commission of the People's Republic of China, Natural Science Foundation of Zhejiang Province

Awards: G6009454914, G7037396057, G965860911

OpenAlex ID: W4402983210

FWCI: 0.808

Cites: 47

Cited by: 7

Related to: 10